Human Molecular Genetics, Vol 5, 649-652, Copyright © 1996 by Oxford University Press
J Hendrickx, E Dams, P Coucke, P Lee, J Fernandes and PJ Willems
X-linked liver glycogenosis type II (XLG II) is a recently described X-
linked liver glycogen storage disease, mainly characterized by enlarged
liver and growth retardation. These clinical symptoms are very similar to
those of XLG I. In contrast to XLG I patients, however, XLG II patients do
not show an in vitro enzymatic deficiency of phosphorylase kinase (PHK).
Recently, mutations were identified in the gene encoding the liver alpha
subunit of PHK (PHKA2) in XLG I patients. We have now studied the PHKA2
gene of four unrelated XLG II patients and identified four different
mutations in the open reading frame, including a deletion of three
nucleotides, an insertion of six nucleotides and two missense mutations.
These results indicate that XLG II is due to mutations in PHKA2. In
contrast to XLG I, XLG II is caused by mutations that lead to minor
structural abnormalities in the primary structure of the liver alpha
subunit of PHK. These mutations are found in a conserved RXX(X)T motif,
resembling known phosphorylation sites that might be involved in the
regulation of PHK. These findings might explain why the in vitro PHK
enzymatic activity is not deficient in XLG II, whereas it is in XLG I.
ARTICLES
X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase
Department of Medical Genetics, University of Antwerp-UIA, Belgium.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. A. Ayers, D. A. Wilkinson, T. J. Fitzgerald, and G. M. Carlson Self-association of the alpha Subunit of Phosphorylase Kinase as Determined by Two-hybrid Screening J. Biol. Chem., December 10, 1999; 274(50): 35583 - 35590. [Abstract] [Full Text] [PDF] |
||||
